The US Food and Drug Administration (FDA) advisory board decided on the 26th to recommend the new coronavirus vaccine made by Pfizer Biontech to children aged 5 to 11 years. rice field. The benefits of inoculation outweigh the risks.
If approved by the FDA, the Centers for Disease Control and Prevention (CDC) Advisory Board will meet next week to discuss the pros and cons of the recommendations. Inoculation may begin as early as next week.
Pfizer announced on the 22nd that it showed 90.7% efficacy in a new coronavirus vaccine clinical trial in 5-11 years old.
Although the number of cases of aggravation and death of children due to the new corona infection is smaller than that of adults, the number of children infected is increasing due to the spread of the highly infectious Delta strain. More than 500 children have died in the country, according to the American Academy of Pediatrics.
Few countries, such as China, Cuba and the United Arab Emirates (UAE), have approved vaccination for children under the age of 11. In the United States, 57% of people have completed vaccination, and only about 47% are between the ages of 12 and 15.